If the agency follows the committee’s advice, it will issue a rule that would allow the compounds to be sold for any condition.
What do you know about difficult-to-treat and treatment-resistant psoriatic arthritis? Test yourself with this quick quiz.
Generic drug manufacturer Major Rugby has issued a voluntary recall of its levothyroxine sodium tablets due to sub-potency. The recall involves 25-µg, 50-µg, 75-µg, 88-µg, 112-µg, 125-µg, and 150-µg ...
A 2023 meta analysis of 28 observational studies found the odds ratio of having prevalent hearing loss was 4.22 for metabolic ...
Hospitals in Germany and Switzerland are reexamining Cardioband use as questions grow over outcomes, safety monitoring, and ...
A power-free fingertip patch continuously monitors levodopa in sweat, with readings that closely correlate with gold-standard blood testing in healthy participants and those with Parkinson’s disease.
Wearables and advanced algorithms are expanding FemTech beyond fertility tracking, but scientific validation, regulation, and privacy remain essential for clinical adoption.
Drs Alexander and Urey walk through stabilizers vs silencers, pivotal trial data, and practical first line choices to help ...
Hot flashes and night sweats are commonly associated with menopause, but many clinicians miss lesser-known menopausal ...
Tafamidis Accord, a generic of Vyndaqel, could widen treatment availability for adults with hereditary transthyretin amyloidosis with cardiomyopathy.
Women with endometriosis-related pelvic pain who participated in supervised exercise and pelvic floor muscle training reported modest improvements in sexual function.
People with moderate-to-severe plaque psoriasis in Europe could soon gain access to the first oral medicine targeting the interleukin (IL)-23 pathway, after the European Medicines Agency’s (EMA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results